Ludwig R, Ludwig C U, Obrecht J P
Schweiz Med Wochenschr. 1984 Dec 15;114(50):1878-83.
While brain metastases from small cell lung cancer are a familiar problem, the incidence of brain metastases from non-small cell lung cancer, and their significance as the first tumor manifestation, has been underestimated. At the University Hospital, Basle, over one year, 7 (approximately 7%) of 102 patients with newly diagnosed non-small cell lung cancer had brain metastases as the first manifestation of systemic cancer. Three of the 7 patients were women with a mean age of 48 years. Initial symptoms were headaches, vertigo and vomiting, which prompted the diagnosis of brain metastases. In only 3 patients was the primary lung cancer diagnosed immediately after diagnosis of the brain metastases, while in the remaining 4 a period of up to 6 months elapsed. Bronchogenic cancer is the most frequent primary in patients presenting with brain metastases. Accordingly, in a patient with brain metastases from an unknown primary, bronchogenic cancer should be considered first and diagnostic tests aimed in that direction. This may obviate an extended and expensive diagnostic workup.
虽然小细胞肺癌脑转移是一个常见问题,但非小细胞肺癌脑转移的发生率及其作为首发肿瘤表现的重要性一直被低估。在巴塞尔大学医院,一年多来,102例新诊断的非小细胞肺癌患者中有7例(约7%)以脑转移作为全身癌症的首发表现。这7例患者中有3例为女性,平均年龄48岁。初始症状为头痛、眩晕和呕吐,这些症状促使诊断为脑转移。仅3例患者在脑转移诊断后立即诊断出原发性肺癌,而其余4例患者则经过了长达6个月的时间才诊断出原发性肺癌。支气管源性癌是出现脑转移患者中最常见的原发肿瘤。因此,对于不明原发灶的脑转移患者,应首先考虑支气管源性癌,并针对该方向进行诊断性检查。这可能避免冗长且昂贵的诊断性检查。